Caris secured a new term loan facility of up to $550M, with an initial draw of $400M in April 2026.
Filing excerpt
Our borrowings under the 2026 Term Loan also subject us to market risk associated with movements in interest rates associated with a forward-looking SOFR. We had $400.0 million in variable rate debt outstanding as of June 30, 2026.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
sec-10qdebtRefinancingGet every 10-Q signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/cce1201a-c865-4545-bb89-cdf5a245bc96 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "cce1201a-c865-4545-bb89-cdf5a245bc96",
"signal_type": "sec-10q",
"signal_subtype": "debtRefinancing",
"detected_at": "2026-08-11T08:11:00.347+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "Caris secured a new term loan facility of up to $550M, with an initial draw of $400M in April 2026. This influx of capital is intended to fund operations, commercial expansion, and R&D, indicating available budget for strategic projects.",
"metrics": {
"timeframe": "current_quarter",
"dollar_context": "Initial draw from new senior secured term loan facility, which has a total capacity of $550M.",
"dollar_millions": 400
},
"summary": "Secured $400M in new term loan financing from Blue Owl Capital in Q2 2026",
"excerpts": "Our borrowings under the 2026 Term Loan also subject us to market risk associated with movements in interest rates associated with a forward-looking SOFR. We had $400.0 million in variable rate debt outstanding as of June 30, 2026.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000055/cai-20260630.htm",
"filing_date": "2026-08-05",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Capital available or pressure",
"signal_category": "financial",
"vendors_mentioned": [
"Blue Owl Capital Corporation"
]
}
}
curl https://signals.autobound.ai/v1/signals/cce1201a-c865-4545-bb89-cdf5a245bc96 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.